DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Schuster J, Lai RK, Recht LD. et al.
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
Neuro Oncol 2015;
17: 854-861
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.